VA Grants 5-year Extension to FSS Contract for NATROX® O₂ Continuous Topical Oxygen Therapy (cTOT)

The U.S. Department of Veterans Affairs (VA) has granted a five-year extension to our Federal Supply Schedule (FSS) contract. This marks another milestone in our mission to support clinicians and empower patients by providing NATROX® O₂ Continuous Topical Oxygen Therapy (cTOT)—a wearable device that has helped Veterans across the United States improve healing outcomes, reduce wound-related pain, and regain their quality of life.

With this extension, we look forward to providing those within the VA, Community Care Network, and Indian Health Service with an effective, user-friendly therapy that can be used across all care settings. Together, we’ll continue advancing wound care and making a real difference in the lives of Veterans, patients, and their families. Learn more about NATROX® O₂ at the VA by visiting link below. FSS Contract Number for NATROX® O₂ Therapy Kit: 36F79720D0094;
ECAT: SPE2DE-20-D-0024; UEI: VCUECDMPYB75